tulobuterol has been researched along with Congenital Myasthenia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyana, K | 1 |
| Ishiyama, A | 1 |
| Saito, Y | 1 |
| Nishino, I | 1 |
1 other study available for tulobuterol and Congenital Myasthenia
| Article | Year |
|---|---|
Tulobuterol is a potential therapeutic drug in congenital myasthenic syndrome.
Topics: Adrenergic beta-2 Receptor Agonists; Humans; Myasthenic Syndromes, Congenital; Terbutaline | 2022 |